We leverage 20 years of experience in science, medicine, FDA/regulatory affairs, and industry to analyze companies at a highly technical level. This detailed analysis defines our due diligence process and gives syndicate investors a high level of confidence in our portfolio companies.
ENDEAVOR LIFE SCIENCE VENTURE FUNDS AND VENTURE STUDIO